Not yet recruiting NCT06640439
LED Therapy for Third Molar Surgery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: photobiomodulation, Antibiotic.
- Who it may be relevant to
- Registry conditions: Molar, Third, Photobiomodulation, Photobiomodulation Therapy, Third Molar Surgery. Basic parameters: 20 years — 55 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
LED Therapy Using 830 Nm in the Mandibular Third Molar Surgery: Double-blind Randomized Clinical Trial.
Overview
LED Therapy for third molar surgery
Detailed description
LED Therapy using 830 nm in the mandibular third molar surgery
Interventions
- Device photobiomodulation
830 nm LED was used to irradiate the post-extraction area - Drug Antibiotic
ibuprofen 0.3 g bid for 3 days, metronidazole 0.1 g tid, and cefaclor 0.375 g bid for 7 days after surgery
Primary outcome measures
- Pain [Time frame: Day 7]
- Swelling [Time frame: Day 3; Day 7]
- Trismus [Time frame: Day 3; Day 7]
Secondary outcome measures (1)
- Quality of life score [Time frame: Day 3; Day 7]
Eligibility criteria
Inclusion criteria
- Healthy Asians;
- 20-55 years old;
- Having mandibular third molars that are inappropriately erupted and need to be extracted due to caries, orthodontic reasons and/or periodontal disease;
Exclusion criteria
- Underlying diseases: diabetes, cardiovascular disease, coagulation disorder, osteoporosis, hypertension, neurological disease, psychological disorder, tumor, systemic infection or cyst at the extraction site;
- Women who are preparing for pregnancy, pregnant or breastfeeding;
- Medication history: use of analgesics, anti-inflammatory drugs and/or antibacterial drugs 2 weeks before tooth extraction, need for systemic medication other than acetaminophen after surgery, allergy to acetaminophen, use of anticoagulants, bisphosphonates;
- Bad habits, such as addicted to smoking, drinking, etc.;
- Volunteers who have recently participated in other clinical trials;
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
China · 1 center
- Huashan Hospital Affiliated to Fudan University — Shanghai
Identifiers
NCT: NCT06640439 · KY2024-1088 · Self-financed